BLI International, Inc.: Drug Recall

Recall #D-0029-2025 · 10/21/2024

Class II: Risk

Recall Details

Recall Number
D-0029-2025
Classification
Class II
Product Type
Drug
Recalling Firm
BLI International, Inc.
Status
Terminated
Date Initiated
10/21/2024
Location
Deer Park, NY, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,901 cases/24 count each case

Reason for Recall

Superpotent Drug: Stability failure for assay at 6 months test time-point.

Product Description

Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24

Distribution Pattern

Product was shipped to two private label customers ( OH & MO) as a final packaged product.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.